04 2010
5th International Conference on Marine Bioprospecting in Tromso; 23-25th February 2011
BIOPROSP is a leading international biennial conference series on bioprospecting from cold marine environments. These conferences aim to present explorative research and its industrial applications in an integrated fashion.
The focus in the 2011 conference will be industrial biotech and bioprospecting as a stepping stone towards the bioeconomy.
Target group: Academic and industry researchers, decision makers, regulatory experts, investors and public facilitators.
A number of interesting speakers from the USA, Russia, UK, Denmark, Switzerland and Norway have been invited. In addition there will be a half day pre-conference workshop: ‘Addressing industrial applications’ on 23 February 2011
Delegates are invited to participate with poster presentations, and a number of posters will be selected for oral presentation.
22 2010
MDPI Publishes New Marine Drugs Issue: Volume 8, Issue 6
MDPI AG announce the publication of the following issue: Mar.
Drugs, Volume 8, Issue 6 (June 2010), Pages 1731-1961 at
http://www.mdpi.com/1660-3397/8/6/
Table of Contents:
Sonia de Caralt, Javier Sánchez-Fontenla, María J. Uriz and Rene H.
Wijffels
Article: In Situ Aquaculture Methods for Dysidea avara (Demospongiae,
Porifera) in the Northwestern Mediterranean
Mar. Drugs 2010, 8(6), 1731-1742; doi:10.3390/md8061731
http://www.mdpi.com/1660-3397/8/6/1731
Charles Santhanaraju Vairappan, Takahiro Ishii, Tan Kai Lee, Minoru Suzuki
and Zhan Zhaoqi
Article: Antibacterial Activities of a New Brominated Diterpene from
Borneon Laurencia spp.
Mar. Drugs 2010, 8(6), 1743-1749; doi:10.3390/md8061743
http://www.mdpi.com/1660-3397/8/6/1743
Ruth Harris, Elena Lecumberri and Angeles Heras
Article: Chitosan-Genipin Microspheres for the Controlled Release of
Drugs: Clarithromycin, Tramadol and Heparin
Mar. Drugs 2010, 8(6), 1750-1762; doi:10.3390/md8061750
http://www.mdpi.com/1660-3397/8/6/1750
João C. Fernandes, Humberto Spindola, Vanessa de Sousa, Alice
Santos-Silva, Manuela E. Pintado, Francisco Xavier Malcata and João E.
Carvalho
Communication: Anti-Inflammatory Activity of Chitooligosaccharides in Vivo
Mar. Drugs 2010, 8(6), 1763-1768; doi:10.3390/md8061763
http://www.mdpi.com/1660-3397/8/6/1763
Xiaomei Wei, Tim S. Bugni, Mary Kay Harper, Imelda T. Sandoval, Elizabeth
J. Manos, Jennifer Swift, Ryan M. Van Wagoner, David A. Jones and Chris M.
Ireland
Article: Evaluation of Pyridoacridine Alkaloids in a Zebrafish Phenotypic
Assay
Mar. Drugs 2010, 8(6), 1769-1778; doi:10.3390/md8061769
http://www.mdpi.com/1660-3397/8/6/1769
Annarita Poli, Gianluca Anzelmo and Barbara Nicolaus
Review: Bacterial Exopolysaccharides from Extreme Marine Habitats:
Production, Characterization and Biological Activities
Mar. Drugs 2010, 8(6), 1779-1802; doi:10.3390/md8061779
http://www.mdpi.com/1660-3397/8/6/1779
Susan Matthew, Ranjala Ratnayake, Mikel A. Becerro, Raphael
Ritson-Williams, Valerie J. Paul and Hendrik Luesch
Article: Intramolecular Modulation of Serine Protease Inhibitor Activity
in a Marine Cyanobacterium with Antifeedant Properties
Mar. Drugs 2010, 8(6), 1803-1816; doi:10.3390/md8061803
http://www.mdpi.com/1660-3397/8/6/1803
Li Liu and Kathleen S. Rein
Review: New Peptides Isolated from Lyngbya Species: A Review
Mar. Drugs 2010, 8(6), 1817-1837; doi:10.3390/md8061817
http://www.mdpi.com/1660-3397/8/6/1817
Amandine Caillaud, Pablo de la Iglesia, H. Taiana Darius, Serge Pauillac,
Katerina Aligizaki, Santiago Fraga, Mireille Chinain and Jorge Diogène
Review: Update on Methodologies Available for Ciguatoxin Determination:
Perspectives to Confront the Onset of Ciguatera Fish Poisoning in Europe
Mar. Drugs 2010, 8(6), 1838-1907; doi:10.3390/md8061838
http://www.mdpi.com/1660-3397/8/6/1838
Bárbara Frazão, Rosário Martins and Vitor Vasconcelos
Article: Are Known Cyanotoxins Involved in the Toxicity of Picoplanktonic
and Filamentous North Atlantic Marine Cyanobacteria?
Mar. Drugs 2010, 8(6), 1908-1919; doi:10.3390/md8061908
http://www.mdpi.com/1660-3397/8/6/1908
Chen Zhang and Se-Kwon Kim
Review: Research and Application of Marine Microbial Enzymes: Status and
Prospects
Mar. Drugs 2010, 8(6), 1920-1934; doi:10.3390/md8061920
http://www.mdpi.com/1660-3397/8/6/1920
Christine J. Band-Schmidt, José J. Bustillos-Guzmán, David J.
López-Cortés, Ismael Gárate-Lizárraga, Erick J. Núñez-Vázquez and
Francisco E. Hernández-Sandoval
Review: Ecological and Physiological Studies of Gymnodinium catenatum in
the Mexican Pacific: A Review
Mar. Drugs 2010, 8(6), 1935-1961; doi:10.3390/md8061935
http://www.mdpi.com/1660-3397/8/6/1935
21 2010
Bioprocessing Data for the Production of Marine Enzymes Now Available
Abstract: This review is a synopsis of different bioprocess engineering approaches adopted for the production of marine enzymes. Three major modes of operation: batch, fed-batch and continuous have been used for production of enzymes (such as protease, chitinase, agarase, peroxidase) mainly from marine bacteria and fungi on a laboratory bioreactor and pilot plant scales. Submerged, immobilized and solid-state processes in batch mode were widely employed. The fed-batch process was also applied in several bioprocesses. Continuous processes with suspended cells as well as with immobilized cells have been used. Investigations in shake flasks were conducted with the prospect of large-scale processing in reactors.
17 2010
Aqua Bio Tech Signs Major Supply Development Agreements
Aqua Bio Technology ASA (ABT), a marine biotechnology and ingredient company, signed two major supply and development agreements. The first agreement is with Bioforskning AS to supply ABT’s patented bioactive ingredient Zonase X™, an ingredient with origins from salmon hatching fluid for use in Bioforskning’s Skin Science professional skincare line. ABT has also secured a major supply and development deal with a global market leader in the health care sector.
Biofoskning’s Skin Science is an exclusive skincare line sold in the Scandinavian professional skincare market. Bioforskning AS is currently preparing a sales expansion of their Skin Science line to several major European markets during the second half of 2010, in addition to developing new lines of products incorporating ingredients such as ABT’s Zonase X, which will be launched during the second half of 2010 and first half 2011.
ABT’s supply and development agreement with the global health care company, who does not wish to be disclosed at this time for strategic reasons, involves development of new products based on certain components contained in ABT’s patented Zonase technology, including Zonase X. The agreement represents a breakthrough for ABT’s new ingredient technology and has significant commercial potential for the company, as it comprises development of products outside of the original application areas of Zonase (which include exfoliation, moisturization and rejuvenation of skin), proving the versatility of the Zonase X technology. A patent application has been filed securing both parties’ common commercial rights within the new product area.
14 2010
Unigen and University of Prince Edward Island Embark on Major Scientific Marine Collection Project
Unigen Pharmaceuticals, Inc., a leading natural products R&D company and proprietary rights supplier, and the University of Prince Edward Island (UPEI), have announced a partnership, which is the first step in an exciting process of collecting marine organisms from the Atlantic Ocean, with an eye to screening the samples for creating therapeutic and commercial products.
Unigen has been collecting plants and other organisms since 1997. Their research and discovery includes extensive work at both the human cell and gene level. Unigen focuses on identifying and studying the unique ingredients of medicinal botanicals and then developing proprietary raw materials for use in cosmeceutical, nutraceutical, functional food and pharmaceutical products. However, the current project will be the first time the company has developed a marine collection.
Researchers anticipate collecting a diverse range of marine organisms – invertebrates such as sponges, corals (non-reef builders), tunicates, and echinoderms, as well as algae, all of which will provide a wealth of information that will lead to discoveries of new chemical entities and novel natural, therapeutic commercial products.
Leading the collection process is Dr. Russell Kerr, Canada Research Chair in Marine Natural Products at UPEI. Dr. Kerr has been collecting and studying specimens in the Florida Keys and the Bahamas for over 20 years.
14 2010
Final Program Available for Marine Biodiscovery Event in the UK, June 2010
This meeting, coinciding with the opening of the new £1.6M Marine Biodiscovery Centre, will address the potential for new products and processes from the marine environment, with a particular emphasis on the technical challenges and realising successful outcomes. This will cover novel pharmaceuticals and high value chemicals such as biomaterials, nutraceuticals and personal care products as well as novel enzymes with unique activities. Academic and industrial aspects will be presented and there will be a showcase for Scottish companies and facilities.
06 2010
Marine Ingredients Poised For Accelerated Development
Inside Cosmeceuticals posted an editorial feature we recently wrote on the future for Marine Ingredients. Read more below:
————————
Many believe the ocean is where life first started. Then it is no surprise, perhaps, that the biggest potential source for new, bioactive ingredients for the health and beauty market may originate from the same place. With so many new species of marine life still to be discovered, the potential for new marine-derived compounds and extracts is immense, and the industry is poised for accelerated development in the near future.
Later this year, the final results of the Census of Marine Life will be revealed. This 10-year ambitious initiative, driven by a global network of researchers in about 80 nations, is intended to assess and explain the diversity, distribution and abundance of marine life in the world’s oceans. This massive study will tell us about newly identified marine organisms and marine life not previously known. This news is exciting, as new promising bacteria, organisms and compounds will be likely discovered, providing a potential treasure trove of new marine ingredient products.
30 2010
Norwegian natural marine ingredient set to revolutionize anti-aging market
The new marine ingredient offers multiple applications including gentle exfoliation and moisturizing, shown to accelerate new skin cell growth.
Aqua Bio Technology AS (ABT), a Norwegian marine biotechnology company developing innovative active ingredients for the global personal care industry, today announced the global launch of ZONASE X™, a natural anti-aging ingredient composed of marine peptides and unique, non-toxic marine enzymes. Following successful launch in the highly demanding Scandinavian market, ZONASE X™ is now ready for the global market.
The primary benefit of the unique ZONASE X is gentle, yet effective exfoliation, making it a safe and natural alternative to α-hydroxy acid, harsh fruit enzyme peels, and other potentially caustic exfoliating agents. In addition, the ingredient has shown excellent moisturizing properties, allowing for accelerated skin cell growth. “The anti-aging category is driving the market, with forecasts of double-digit growth over the next five years,” said Thor Arne Talseth, Executive Chairman. “Our testing shows that all-natural ZONASE X is as effective as other exfoliants on the market – yet does not have the same abrasive qualities and is far gentler on the skin. It also offers a moisturizing benefit, providing additional value. These positive attributes have been very well-received during Scandinavian launch, and we believe this unique discovery could quickly become a dominant ingredient within the anti-aging segment.”
ZONASE X was first discovered at the salmon fish hatcheries in Norway, where hatchery staff members had surprisingly smooth hands – despite being immersed in intensely cold water for long periods. Their smooth skin was in fact due to an enzyme in the water secreted by fish larvae inside the egg just prior to hatching. This enzyme helps to break the egg shell during hatching — without harming the highly fragile larvae inside. Further research on this new enzyme indicated that the egg shell had a protein structure akin to corneum proteins of human skin. Thus, the connection to the smooth hands was made – and a new, natural and gentle exfoliant was discovered.
22 2010
Marine Biodiscovery: Research & Applications Meeting; 15-16 June 2010 – University of Aberdeen, Scotland, UK
This meeting, coinciding with the opening of the new £1.6M Marine Biodiscovery Centre, will address the potential for new products and processes from the marine environment, with a particular emphasis on the technical challenges and realising successful outcomes. This will cover novel pharmaceuticals and high value chemicals such as biomaterials, nutraceuticals and personal care products as well as novel enzymes with unique activities. Academic and industrial aspects will be presented and there will be a showcase for Scottish companies and facilities.
Topics:
- Accessing and assessing marine biodiversity
- Molecular methods to find and express secondary metabolites and enzymes.
- Extraction and isolation of small molecules & modern methods for structural characterisation
- Marine bioinorganic chemistry
- Screening marine natural products
- Applications in the nutraceuticals and personal care market.
- Applications in the high value markets for instance pharmaceuticals and enzymes.
- Taking marine pharmaceuticals to the market
- Marine biomaterials
22 2010
Converted Organics in New Jersey to accept food waste from fish firm
Converted Organics Inc. (NASDAQ:COIN) recently announced that the Company and Acme Smoked Fish Corporation, one of the largest processors of smoked fish and herring in the United States, have agreed to work together in the collection, processing and conversion of food waste from Acme. Acme is a client of Brooklyn, N.Y.-based Filco Environmental Services, which has provided Converted Organics with organic waste from its food service clients since 2008.
“Acme Smoked Fish is a tremendous source of high-quality organic nutrients for our all-natural organic fertilizers. We are very pleased that our long-standing associate Filco Environmental Services facilitated this mutually beneficial relationship between Converted Organics and Acme,” said Jack Walsdorf, Vice President of Waste Management for Converted Organics. “Food waste from fish processing plays an important role in our California operation, and we expect it will be a valuable component of the organic fertilizer products manufactured in our New Jersey plant as we prepare for the upcoming spring 2010 growing season.”
RSS Feed 
Search
News Archive
Categories
Host
 |
Partners
 |
Sponsors
 |  |
Latest News
- Why fish oils work against diabetes
- Shellfish make great plastic; Research out of Australia
- Microalgae Industry Internet Directory Launched
- Maryland Aquarium Unveils New Conservation Center, Expanding Research
- Algenics Signs With Roquette For The Development Of An Innovative Microalgae Strain For High Value Industrial Uses
Recent Comments
- sitharth on Blue Bio Open Innovation (BBOI): Norway and Sweden Collaborate on Joint Marine Biotech Development
- Tweets that mention Aquapreneur - Sponge Genome Reveals Animal, Cancer Origins -- Topsy.com on Sponge Genome Reveals Animal, Cancer Origins
- Horris on GlycoMar files four patents advancing search for new drugs from the sea
- Tweets that mention Aquapreneur - Ongoing Project Aims to Recover Nutritional Value From Seafood and Brewing Waste -- Topsy.com on Ongoing Project Aims to Recover Nutritional Value From Seafood and Brewing Waste
- Twitted by Aquapreneur on “Jelloware” Drinking Cups from Seaweed Extract
Share Aquapreneur
